The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stievano, L.
Right arrow Articles by Amadori, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stievano, L.
Right arrow Articles by Amadori, A.
The Journal of Immunology, 2003, 171: 4528-4538.
Copyright © 2003 by The American Association of Immunologists

CD8+{alpha}{beta}+ T Cells That Lack Surface CD5 Antigen Expression Are a Major Lymphotactin (XCL1) Source in Peripheral Blood Lymphocytes 1

Laura Stievano, Valeria Tosello, Novella Marcato, Antonio Rosato, Annalisa Sebelin, Luigi Chieco-Bianchi and Alberto Amadori2

Department of Oncology and Surgical Sciences, University of Padova, Padova, Italy

To better characterize the cellular source of lymphotactin (XCL1), we compared XCL1 expression in different lymphocyte subsets by real-time PCR. XCL1 was constitutively expressed in both PBMC and CD4+ cells, but its expression was almost 2 log higher in CD8+ cells. In vitro activation was associated with a substantial increase in XCL1 expression in both PBMC and CD8+ cells, but not in CD4+ lymphocytes. The preferential expression of XCL1 in CD8+ cells was confirmed by measuring XCL1 production in culture supernatants, and a good correlation was found between figures obtained by real-time PCR and XCL1 contents. XCL1 expression was mostly confined to a CD3+CD8+ subset not expressing CD5, where XCL1 expression equaled that shown by {gamma}{delta}+ T cells. Compared with the CD5+ counterpart, CD3+CD8+CD5- cells, which did not express CD5 following in vitro activation, showed preferential expression of the {alpha}{alpha} form of CD8 and a lower expression of molecules associated with a noncommitted/naive phenotype, such as CD62L. CD3+CD8+CD5- cells also expressed higher levels of the XCL1 receptor; in addition, although not differing from CD3+CD8+CD5+ cells in terms of the expression of most {alpha}- and {beta}-chemokines, they showed higher expression of CCL3/macrophage inflammatory protein-1{alpha}. These data show that TCR {alpha}{beta}-expressing lymphocytes that lack CD5 expression are a major XCL1 source, and that the contribution to its synthesis by different TCR {alpha}{beta}-expressing T cell subsets, namely CD4+ lymphocytes, is negligible. In addition, they point to the CD3+CD8+CD5- population as a particular T cell subset within the CD8+ compartment, whose functional properties deserve further attention.




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
Y. Nishimura, M. Shimojima, E. Sato, Y. Izumiya, Y. Tohya, T. Mikami, and T. Miyazawa
Downmodulation of CD3{varepsilon} expression in CD8{alpha}+{beta}- T cells of feline immunodeficiency virus-infected cats
J. Gen. Virol., September 1, 2004; 85(9): 2585 - 2589.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.